ClinicalTrials.gov record
Completed Phase 1 Interventional

Oral Fecal Transplant in Cirrhosis

ClinicalTrials.gov ID: NCT03152188

Public ClinicalTrials.gov record NCT03152188. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 14, 2026, 7:21 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Modulation of Gut-Brain Axis Using Fecal Transplant Capsules in Cirrhosis

Study identification

NCT ID
NCT03152188
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Virginia Commonwealth University
Other
Enrollment
20 participants

Conditions and interventions

Interventions

  • FMT Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
21 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 11, 2017
Primary completion
Nov 11, 2018
Completion
Nov 11, 2018
Last update posted
May 18, 2021

2017 – 2018

United States locations

U.S. sites
2
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Hunter Holmes McGuire VA Medical Center Richmond Virginia 23249
Virginia Commonwealth University Richmond Virginia 23298

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03152188, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 18, 2021 · Synced May 14, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03152188 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →